Literature DB >> 34261991

Power Reserve at Intolerance in Ramp-Incremental Exercise Is Dependent on Incrementation Rate.

Matthew J Davies1, Gemma K Lyall1, Alan P Benson1, Daniel T Cannon2, Karen M Birch1, Harry B Rossiter, Carrie Ferguson1.   

Abstract

INTRODUCTION: The mechanism(s) of exercise intolerance at V˙O2max remain poorly understood. In health, standard ramp-incremental (RI) exercise is limited by fatigue-induced reductions in maximum voluntary cycling power. Whether neuromuscular fatigue also limits exercise when the RI rate is slow and RI peak power at intolerance is lower than standard RI exercise, is unknown.
METHODS: In twelve healthy participants, maximal voluntary cycling power was measured during a short (~6 s) isokinetic effort at 80 rpm (Piso) at baseline and, using an instantaneous switch from cadence-independent to isokinetic cycling, immediately at the limit of RI exercise with RI rates of 50, 25, and 10 W·min-1 (RI-50, RI-25, and RI-10). Breath-by-breath pulmonary gas exchange was measured throughout.
RESULTS: Baseline Piso was not different among RI rates (analysis of variance; P > 0.05). Tolerable duration increased with decreasing RI rate (RI-50, 411 ± 58 s vs RI-25, 732 ± 93 s vs RI-10, 1531 ± 288 s; P < 0.05). At intolerance, V˙O2peak was not different among RI rates (analysis of variance; P > 0.05), but RI peak power decreased with RI rate (RI-50, 361 ± 48 W vs RI-25, 323 ± 39 W vs RI-10, 275 ± 38 W; P < 0.05). Piso at intolerance was 346 ± 43 W, 353 ± 45 W, and 392 ± 69 W for RI-50, RI-25, and RI-10, respectively (P < 0.05 for RI-10 vs RI-50 and RI-25). At intolerance, in RI-50 and RI-25, Piso was not different from RI peak power (P > 0.05), thus there was no "power reserve." In RI-10, Piso was greater than RI peak power at intolerance (P < 0.001), that is, there was a "power reserve."
CONCLUSIONS: In RI-50 and RI-25, the absence of a power reserve suggests the neuromuscular fatigue-induced reduction in Piso coincided with V˙O2max and limited the exercise. In RI-10, the power reserve suggests neuromuscular fatigue was insufficient to limit the exercise, and additional mechanisms contributed to intolerance at V˙O2max.
Copyright © 2021 by the American College of Sports Medicine.

Entities:  

Year:  2021        PMID: 34261991     DOI: 10.1249/MSS.0000000000002645

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  2 in total

1.  Skeletal muscle biochemical origin of exercise intensity domains and their relation to whole-body V̇O2 kinetics.

Authors:  Bernard Korzeniewski; Harry B Rossiter
Journal:  Biosci Rep       Date:  2022-08-31       Impact factor: 3.976

2.  A randomized, crossover, placebo controlled, double-blind trial of the effects of tiotropium-olodaterol on neuromuscular performance during exercise in COPD.

Authors:  Min Cao; Robert A Calmelat; Peter Kierstead; Nicolo Carraro; William W Stringer; Janos Porszasz; Richard Casaburi; Harry B Rossiter
Journal:  J Appl Physiol (1985)       Date:  2022-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.